DNACPR Decision Framework
Guides clinicians through factors informing a DNACPR (Do Not Attempt Cardiopulmonary Resuscitation) decision using GMC/BMA/RCN framework.
Score interpretation
→ Document discussion; consider time-limited trial; involve senior clinician; respect patient choice; review if condition changes
→ Inform patient/family in sensitive discussion; document on standard DNACPR form; explain does not affect other treatments; review regularly
→ Complete DNACPR documentation; communicate to all care settings (GP, out-of-hours, ambulance); ensure Respect/ReSPECT form completed; file in notes and accessible location
Interpretation bands for the DNACPR Framework. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Lipid Emulsion 20% (Intralipid) · Antidote / Resuscitation
- Lipid Emulsion 20% (Intralipid) · Antidote / Resuscitation
- Gaviscon Advance (Alginate Preparation) · Alginate / Antacid Combination
- Sodium alginate with calcium carbonate and sodium bicarbonate · Reflux suppressant (alginate raft + antacid)
- Alginic Acid · Antacid / Alginate (GORD Treatment)
- Factor IX Concentrate · Coagulation Factor Replacement — Haemophilia B
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.